Patient
SITE001-0216
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2026-05-13
Adverse events
5
Serious AEs
1
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 5
Grade 1 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2023-02-17 (study day 91); relationship: not assessed
Grade 3 Rash — outcome: RECOVERED/RESOLVED; onset 2023-02-03 (study day 77); relationship: RELATED; serious criteria: hospitalization
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2023-01-29 (study day 72); relationship: RELATED
Grade 2 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-01-08 (study day 51); relationship: NOT RELATED
Grade 2 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2022-12-27 (study day 39); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.